An interventional study to access the effect of Homoeopathic medicine Arsenicum album 30 C as a prohylaxis in high risk population exposed to COVID-19.

A prospective interventional study on the effect of Arsenicum album 30 C as a prophylactic measure among High risk population exposed to COVID-19. - ARCOV

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/06/026056

Enrollment

5000

Registered

2020-06-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Arsenicum album 30 C: Arsenicum album 30 C Once Daily for 3 consecutive days early morning in empty stomach. One adult dose is 5 globules of no. 30 medicated globule One child dose is 3

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects of high risk population. 2. Male or female subjects above the age of 03 years to 65 years. 3. Subject who are ready to provide written/digital informed consent and who are willing to participate and follow the protocol requirements of the clinical study.

Exclusion criteria

Exclusion criteria: 1. Pregnant and Lactating woman. 2. Subjects having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening. 3. Subjects who are on any other regular medication( Alternative/ Modern)for any other ailments. 4. Subjects participating in any other clinical study or having participated in any other study one month prior to screening in the present study. 5. Subjects having a past history of allergy to any medicine that is part of the Homoeopathic intervention. Other conditions, which in the opinion of the investigators, makes the patient unsuitable for enrolment or could interfere with his participation in, and completion of the protocol.

Design outcomes

Primary

Measure	Time frame
To assess of occurrence of COVID-19 infection in healthy volunteers exposed to COVID-19 in the communityTimepoint: 6 months	—

Secondary

Measure	Time frame
1. To assess the immunity status of the participants taking Arsenicum album -30 C 2. To evaluate the occurance of advarse event for safety assessment of Arsenicum album-30C.Timepoint: 6 months	—

Countries

India

Contacts

Public ContactDr Tapan Nath

North Eastern Institute of Ayurveda and Homoeopathy (NEIAH)

tapanbngn@gmail.com8837349308

Outcome results